Circulating adiponectin level is associated with major adverse cardiovascular events in type 2 diabetic patients with coronary artery disease

Elevated levels of circulating adiponectin (ADPN), an anti- inflammatory and anti-oxidative peptide, are associated with unfavorable cardiovascular outcomes in patients with cardiovascular diseases. The aim of this study was to investigate whether plasma ADPN levels could help predict major adverse...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Endocrine Journal 2010, Vol.57(9), pp.793-802
Hauptverfasser:	Hung, Wei-Chin, Wang, Chao-Ping, Lu, Li-Fen, Yu, Teng-Hung, Chiu, Cheng-An, Chung, Fu-Mei, Chen, Han-Jung, Houng, Jer-Yiing, Shin, Shyi-Jang, Lee, Yau-Jiunn
Format:	Artikel
Sprache:	eng
Schlagworte:	Adiponectin - blood Adult Aged Aged, 80 and over Cardiovascular Diseases - etiology Cardiovascular Diseases - mortality Coronary artery disease Coronary Artery Disease - complications Diabetes Mellitus, Type 2 - complications Female Humans Kaplan-Meier Estimate Major adverse cardiovascular events (MACE) Male Middle Aged Myocardial Infarction - etiology Plasma adiponectin Risk Factors Stroke - etiology Treatment Outcome Type 2 diabetes mellitus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!